Andrew J. Young, MD1 and Therese M. Duane, MD2 1 Department of Trauma, Critical Care and Burn, The Ohio State University, Columbus, OH, USA 2 TCU & UNTHSC School of Medicine, Department of Surgery, Texas Health Resources, Fort Worth, TX, USA Calciphylaxis is a difficult disease to treat. It typically occurs in patients with chronic kidney disease. Patients typically die from sepsis due to the wounds caused by calciphylaxis. The etiology of this disease has yet to be elucidated, but there are known risk factors. Medications that can cause this disease include warfarin, calcium, vitamin D, iron, and recombinant PTH. Thus, these should be stopped once the diagnosis of calciphylaxis is made. Answer E is correct. The other medications have not been associated with increased risk of calciphylaxis. Answer: E McCarthy JT, el‐Azhary RA, Patzelt MT, et al. Survival, risk factors, and effect of treatment in 101 patients with calciphylaxis. Mayo Clinic Proceedings 2016; 91(10):1384–1394. doi:10.1016/j.mayocp.2016.06.025 Nigwekar SU, Thadhani R, and Brandenburg VM . Calciphylaxis. The New England Journal of Medicine 2018; 378(18):1704–1714. doi:10.1056/NEJMra1505292 This patient has diabetes insipidus (DI), which is a deficiency of antidiuretic hormone (ADH). There are two types of DI – central and nephrogenic. This patient most likely has central DI from his brain injury. Administration of exogenous ADH helps differentiate between the two types of DI. If the patient responds to the ADH (urine out decreases and becomes more concentrated), then it is central DI. If the patient does not respond to the exogenous ADH, then it is nephrogenic. Initial treatment consists of increasing free water to try and correct the hyperosmolarity. There may also be elevated serum potassium and calcium. Free water administration may also correct these abnormalities. Initial administration of free water should occur enterally if access is available, thus answer C is correct, otherwise the next best choice is answer B. Answer A is incorrect because this may worsen the hypernatremia. This patient does not have thyroid insufficiency, so answer d is incorrect. While this patient may become hypovolemic due to the high urine output, there is no current recommendation for a specific fluid replacement protocol (answer E). Answer: C Capatina C, Paluzzi A, Mitchell R, et al. Diabetes insipidus after traumatic brain injury. Journal of Clinical Medicine 2015; 4(7):1448–1462. doi:10.3390/jcm4071448 There is still much debate regarding steroids in septic shock; however, the current surviving sepsis guidelines recommend against start corticosteroids. In a patient who is responsive to fluid resuscitation and vasopressors, steroids should not be empirically started. Answer: E Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine 2017; 43(3):304–77. doi:10.1007/s00134‐017‐4683‐6 Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. The New England Journal of Medicine 2018; 378(9):797–808. doi:10.1056/NEJMoa1705835 While the exact target range for appropriate blood glucose level has had much debate, there is consensus that hyperglycemia can cause harm. Detrimental effects include worse outcomes in patients with traumatic brain injury, decreased gut motility potentially leading to bacterial overgrowth and translocation, and is a risk factor for infection (answer E). Answer: E Brealey D and Singer M . Hyperglycemia in critical illness: a review. Journal of Diabetes Science and Technology 2009; 3(6):1250–1260. doi:10.1177/193229680900300604 Krinsley JS . Glycemic control in the critically ill: what have we learned since NICE‐SUGAR? Hospital Practice 2015; 43(3):191–197. doi:10.1080/21548331.2015.1066227 Tight blood glucose control was first promulgated in 2001 with the publication of a trial that demonstrated that “tight” (80–110 mg/dL) blood glucose control improved mortality in the intensive care unit. Subsequent studies failed to reproduce this, and this was further debunked in 2009 with the publication of the NICE‐SUGAR trial, which found that with moderate blood glucose control (a goal of <180mg/dL) have improved outcomes. However, later studies found that in patients with a history of diabetes, a higher blood glucose target was associated with better outcomes. Answer: C Finfer S, Bellomi R, Blair D, et al. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 2009; 360(13):1283–1297. doi:10.1056/NEJMoa0810625 Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Critical Care 2013; 17(2):R37. doi:10.1186/cc12547 The patient is experiencing an Addisonian crisis (primary adrenal insufficiency), which consists of hypotension, vomiting, diarrhea, hyperkalemia, hypercalcemia, fever, syncope, lethargy, and abdominal pain. Patients should be placed on replacement therapy prior to adrenalectomy and continue with therapy afterwards to prevent hypocortisolism. Therapy includes treatment for both mineralocorticoid and glucocorticoid deficiency (fludrocortisone and hydrocortisone, respectively). When a patient is in crisis, they require high‐dose steroid therapy (hydrocortisone 100 mg every 8 hours), fluid resuscitation, electrolyte correction, and intensive care monitoring. Answer: B Charmandari E, Nicolaides NC, and Chrousos GP . Adrenal insufficiency. The Lancet. 2014; 383(9935):2152–2167. doi:10.1016/S0140‐6736(13)61684‐0 Myxedema coma is a rare phenomenon, so one must have a high index of suspicion in order to make the diagnosis. The mortality rate is high given that there is usually a precipitating event (infection in this case), which can cloud the diagnosis. High TSH in the setting of profound hypothermia and unconsciousness should lead one to suspect the diagnosis. Admission to an intensive care unit is recommended along with concomitant treatment of respiratory failure, electrolyte abnormalities, vasoplegia, and cardiac depression. Treatment should focus on airway control due to patients having a mixed hypoxic and hypercapnic picture of respiratory failure. There is controversy surrounding whether or not to give T3 or T4, thus some recommend giving both. T3 will have a fast onset, while T4 will have a slow, steady onset depending on the patient’s deiodinase activity. Answer: B Wartofsky L and Klubo‐Gwiezdzinska J . Myxedema coma. In: Luster M, Duntas LH, Wartofsky L, eds. The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician. Springer International Publishing; 2019:281–292. doi:10.1007/978‐3‐319‐72102‐6_20
15
Metabolic Illness and Endocrinopathies